A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease

Conditions: Fabry Disease Interventions: Drug: PRX-102 1 mg/kg every two weeks Sponsors: Chiesi Farmaceutici S.p.A.; ICON plc Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials